Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Secosan C, Balint O, Pirtea L, Grigoras D, Balulescu L, Ilina R
"The 44% reduction in all-cause mortality observed among patients with obesity and co-occurring autoimmune disease is a striking finding that demands our attention, said Fatima Cody Stanford, M.D., M.P.H., M.P.A., M.B.A., FAHA and member of the American Heart Associations Lifestyle and Cardiometabolic Council
PMID 24683506
Characterized initially for their role in postprandial stimulation of pancreatic insulin secretion, these agents found original clinical use in the early 2000s for the reduction of hyperglycemia
GLP-1 agonist drugs are most often used to help type 2 diabetes patients lower their blood sugars or to help patients with heart disease prevent heart attacks or strokes, but some also can help treat obesity and soon could be approved for sleep apnea and other treatments
With our deep scientific foundation, our ambition is to be the most evidence-based and transformative food company in the world you can trust your gut with us.
US$ 24.85
US$ 21.29
US$ 29.07
US$ 27.23
US$ 25.72
US$ 25.18
US$ 20.28
